After several delays, the US Food and Drug Administration has finally clearedInsulet's Omnipod 5 tubeless insulin delivery system to help diabetic users manage their glucose without daily injections or fingersticks.
Omnipod 5 integrates with Dexcom’s G6 continuous glucose monitor (CGM) and a smartphone app to automatically adjust insulin levels to prevent highs and lows. The user can also control the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?